About Us ten23 health is a human-centric and sustainable strategic partner of choice for the pharmaceutical industry and biotech start-ups for the development, manufacture, and testing of tomorrow’s medicines. We support our clients in developing differentiated, stable,
Join our Mission to Protect Humankind! Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working
About Us ten23 health is a human-centric and sustainable strategic partner of choice for the pharmaceutical industry and biotech start-ups for the development, manufacture, and testing of tomorrow’s medicines. We support our clients in developing differentiated, stable,
Our unique biological manufacturing and development concept in Visp, Switzerland, offers a complete product lifecycle of a biopharmaceutical – from preclinical to commercial stages, from drug substance to drug product, all in one location. The three offerings
Ibex Solutions (www.ibex.lonza.com), our recently launched unique biological development and manufacturing concept in Visp, Switzerland, offers a complete product lifecycle of a biopharmaceutical – from preclinical to commercial stages, from drug substance to drug product, all in
Location: the actual location of this job is in Visp, Switzerland. Relocation assistance is available for eligible candidates and their families, if needed. The QA Logistics group provides key QA oversight and support for the Visp
The actual location of this job is in Visp, Switzerland. Relocation assistance is available for eligible candidates and their families, if needed. We are seeking an experienced Chemist / Chemical Engineer (m/f/d) with strong expertise in
The site in is growing and for our Biologics organization, we are currently looking for experienced Process Experts and Senior Process Experts in , our recently launched unique biological manufacturing and development concept. We have opportunities in